SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer

Serine-rich splicing factor3 (SRSF3) plays an essential role in cell proliferation and inducing and maintaining of cancers as a proto-oncogene. However, the mechanisms of SRSF3 in pan-cancers are still unknown. In our study, a visualized prognostic landscape of SRSF3 in pan-cancer was investigated a...

Full description

Bibliographic Details
Main Authors: Huang, H. (Author), Li, Z. (Author), Shang, A. (Author), Wu, X. (Author), Xiao, F. (Author), Yang, Y. (Author), Yu, T. (Author), Zhou, H. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
overall survival
pan-cancer
prognostic biomarkers
SRSF3
TCGA
Online Access:View Fulltext in Publisher

Similar Items

Similar Items